Rap­port bags $150M Se­ries B just five months af­ter nine-fig­ure launch for epilep­sy, psy­chi­a­try tri­als

Just five months af­ter emerg­ing with $100 mil­lion to test for­mer Janssen neu­ro­science pro­grams, Rap­port Ther­a­peu­tics is back with an­oth­er nine-fig­ure raise to take its …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER